SGH delivers strong first-half FY26 earnings with higher dividend

SGH delivered a solid half-year FY26 result with higher earnings, strong cash flow, and an increased dividend.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The SGH Ltd (ASX: SGH) share price is in focus after the company posted a robust half-year FY26 result, with EBIT holding steady at $844 million and NPAT rising 2% to $518 million. Operating cash flow jumped 32% to $1.1 billion, and a 7% higher fully franked interim dividend of 32 cents per share was declared.

A share market analyst looks at his computer screen in front of him showing ASX share price movements

Image source: Getty Images

What did SGH report?

  • Revenue of $5.4 billion, down 2% from 1HY25
  • EBIT of $844 million, flat year-on-year, up 22% on 2H FY25
  • NPAT of $518 million, up 2% on the prior corresponding period
  • EBITDA of $1.1 billion, up 1%
  • Operating cash flow of $1.1 billion, up 32%
  • Interim fully franked dividend of 32 cents per share, up 7%

What else do investors need to know?

SGH saw EBIT margin expand 30 basis points to 15.6%, mainly driven by Boral and WesTrac performing strongly thanks to operating leverage and cost initiatives. Boral posted a 10% EBID growth, while continued focus on cash generation helped lower the adjusted net debt to EBITDA ratio to 1.9x, giving SGH extra financial flexibility.

Safety remains a top priority, with the company reporting a 36% reduction in Lost Time Injury Frequency Rate and further progress on operational safety across its businesses. The group also refinanced debt, securing longer maturities and reducing funding costs, with over $2.2 billion in liquidity available at the end of December.

What did SGH management say?

Managing Director & CEO Ryan Stokes said:

We are pleased to deliver a strong result for the first half of FY26. It demonstrates the strength and resilience of our diversified industrial businesses. In a dynamic market, we delivered earnings growth in our core Industrial Services segment, expanded our margins, and generated significant growth in operating cash flow.

What's next for SGH?

SGH heads into the second half of FY26 with solid operational momentum and a balanced outlook across its sectors. The company is sticking with its "SGH Way" operating model, focusing on sales execution, efficiency, and innovation.

Management reiterated guidance for "low to mid single-digit EBIT growth" for FY26, supported by balanced market exposures and ongoing cost control. Investors can expect ongoing investment into key projects and disciplined capital management.

SGH share price snapshot

Over the past 12 months, SGH shares have declined 4%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 5% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Earnings Results

Doctor doing a telemedicine using laptop at a medical clinic
Earnings Results

Guess which ASX 200 stock is jumping 9% on FY26 results

This medical device company has released its FY 2026 results. Let's see what it reported.

Read more »

A man sitting in an aeroplane seat holds the top of his head as he looks at his airline ticket with an annoyed, angry expression on his face.
Earnings Results

Webjet shares crash 15% as Virgin Australia blow hits outlook

Webjet shares are under heavy pressure after its latest update.

Read more »

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Earnings Results

James Hardie shares tumble on FY26 profit crunch

Investors have been hitting the sell button on Wednesday. Let's find out why.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Earnings Results

Why are Catapult Sport shares jumping 18% today?

This sports technology company has delivered a stronger than expected FY 2026 result.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Which ASX 200 share is crashing 22% on half-year results?

Let's see why investors are hitting the sell button on Monday.

Read more »

A man in a suit looks surprised as he looks through binoculars.
Earnings Results

Guess which ASX 200 stock is dropping despite record quarterly profit

It was a record-breaking quarter for this company.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Earnings Results

Why Xero shares are falling despite a big jump in revenue

Xero shares are under pressure as Melio costs weigh on profit.

Read more »

A man looking at his laptop and thinking.
Earnings Results

ASX 200 stock crashes 12% on half-year results

Profit is down but its guidance has been reaffirmed.

Read more »